We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

BIO-RAD LABORATORIES

Provides full range of instrumentation, reagent kits, software and quality control systems to clinical laboratories. ... read more Featured Products: More products

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
16 Aug 2021 - 26 Aug 2021
Virtual Venue
29 Aug 2021 - 31 Aug 2021
Virtual Venue

Bio-Rad and Seegene Enter into Partnership for Molecular Diagnostic Testing Products

By LabMedica International staff writers
Posted on 02 Jul 2021
Print article
Illustration
Illustration
Bio-Rad Laboratories (Hercules, CA, USA) and Seegene, Inc. (Seoul, Korea) have entered into a partnership for the clinical development and commercialization of infectious disease molecular diagnostic products.

Under the terms of the agreement, Seegene will provide diagnostic tests for use on Bio-Rad’s CFX96 Dx Real-Time PCR System for U.S. markets pending clinical development and clearance from the US Food & Drug Administration (FDA). Seegene assays offer multiplex real-time PCR detection and differentiation, with high sensitivity and specificity of up to seven targets in a single reaction. The assays deliver results in approximately four hours.

“We look forward to working with Seegene to provide needed diagnostic testing products to US markets,” said Dara Wright, Bio-Rad EVP and President, Clinical Diagnostics. “Seegene’s unique assay design, chemistries, and high-level multiplexing can detect multiple infectious disease targets simultaneously, making the assays well-suited for syndromic testing.”

Related Links:
Bio-Rad Laboratories
Seegene, Inc.


Gold Supplier
Sample Transport
VACUETTE Transport Line
New
Quantitative SARS-CoV-2 Neutralizing Antibody ELISA
KTR-1036 EDI Quantitative SARS-CoV-2 Neutralizing Antibody ELISA
New
SARS-CoV-2 LAMP Test
SARS-CoV-2 LAMP Solution
New
POCT Analyzer
HTY-100 Plus POCT Analyzer

Print article

Channels

Molecular Diagnostics

view channel
Image: Primary angle closure glaucoma can cause permanent blindness if not treated quickly. A highly sensitive genetic test has been developed (Photo courtesy of Flinders University)

Highly Sensitive Genetic Test for Glaucoma Developed

In open-angle glaucoma, the angle in the eye where the iris meets the cornea is as wide and open as it should be, but the eye’s drainage canals become clogged over time, causing an increase in internal... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.